TBMIF yields 133333.33% · JNJ yields 2.13%● Live data
📍 TBMIF pulled ahead of the other in Year 1
Combined, TBMIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TBMIF + JNJ for your $10,000?
Big Tree Carbon Inc., a mineral exploration company, engages in the acquisition, exploration, and development of gold properties in Ontario, Canada. It owns 100% interests in the Richardson Lake gold property consisting of 123 mineral cell and 5-cell multicell mineral claims covering an area of approximately 2,220 hectares; and the Western Fold properties comprises 110 mineral cell claims totaling approximately 2,170 hectares located in Brownstone and Casummit Lake Area mining townships, as well as the Richardson North Extension Gold property consisting of 50 mineral cell claims covering an area of approximately 1,010 hectares. The company also holds 100% interest in the Dancing Man Gold property comprises 654 mineral cell claims totaling approximately 13,280 hectares; the Ranger Lake gold property consisting of 236 mineral cell claims covering an area of approximately 4,790 hectares; and the McFaulds Lake property totaling 450 hectares located in Northern Ontario. In addition, it holds 35% interest in the Bridget Lake property that covers an area of approximately 144 hectares situated in Northern Ontario. The company was formerly known as AurCrest Gold Inc. and changed its name to Big Tree Carbon Inc. in April 2022. Big Tree Carbon Inc. is based in Toronto, Canada.
Full TBMIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.